Charifa Awada
Quebec, QC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
The future of group 2 pulmonary hypertension: Exploring clinical trials and therapeutic targets.
Journal: Vascular pharmacology
Published: February 03, 2023
G9a/GLP Targeting Ameliorates Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension.
Journal: American journal of respiratory cell and molecular biology
Published: February 01, 2023
Fetal Gene Reactivation in Pulmonary Arterial Hypertension: GOOD, BAD, or BOTH?
Journal: Cells
Published: May 18, 2021
Implication of EZH2 in the Pro-Proliferative and Apoptosis-Resistant Phenotype of Pulmonary Artery Smooth Muscle Cells in PAH: A Transcriptomic and Proteomic Approach.
Journal: International journal of molecular sciences
Published: February 18, 2021
Preclinical Investigation of Trifluoperazine as a Novel Therapeutic Agent for the Treatment of Pulmonary Arterial Hypertension.
Journal: International journal of molecular sciences
Published: February 16, 2021
Oxidized DNA Precursors Cleanup by NUDT1 Contributes to Vascular Remodeling in Pulmonary Arterial Hypertension.
Journal: American journal of respiratory and critical care medicine
Published: October 06, 2020
R-Crizotinib predisposes to and exacerbates pulmonary arterial hypertension in animal models.
Journal: The European respiratory journal
Published: August 25, 2020
A randomized controlled trial of high-intensity interval training and inspiratory muscle training for chronic heart failure patients with inspiratory muscle weakness.
Journal: Chronic illness
Published: May 07, 2020
Best mode of inspiratory muscle training in heart failure patients: a systematic review and meta-analysis.
Journal: European journal of preventive cardiology
Published: August 04, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026